Immunis

company

About

Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.

  • Irvine,California,United States
  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$10M
Industries
Biotechnology
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Immunis has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Aug 3, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 3, 2022 Series A $10M 1 Remiges Ventures Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Immunis has made 1 investments. Their most recent investment was on May 3, 2017, when Swiftly raised $2.50M.
Date Company Name
Round Money Raised Industry Lead Investor
May 3, 2017 Swiftly
Series Unknown $2.50M Analytics

Investors

Number of Lead Investors
Number of Investors
1
1
Immunis is funded by 1 investors. Remiges Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Remiges Ventures Yes Series A

Employee Profiles

Number of Employee Profiles
2
Immunis has 2 current employee profiles, including Board member Hans Keirstead
Board member
Executive